Download PDF
Zeitschrift für Komplementärmedizin 2017; 09(05): 56-61
DOI: 10.1055/s-0043-116648
Wissen
Demenzprävention
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Lebensstil und Demenz – Befunde und Überlegungen

Harald Walach
Martin Loef
Subject Editor:
Further Information

Publication History

Publication Date:
19 September 2017 (online)

    Permissions and Reprints

Zusammenfassung

Der Fokus der Demenzforschung liegt nach wie vor auf der Untersuchung der molekularen, pathophysiologischen Mechanismen. Wir umreißen in diesem Beitrag einige unserer Befunde, die aus systematischen Überblicksarbeiten der Literatur herrühren. Daraus kann man ableiten, dass Demenz sehr wohl einige Zusammenhänge mit Verhalten, vor allem mit dem Lebensstil und der Ernährung aufweist und daher auch durch entsprechende Lebensstiländerungen präventiv und aktiv angegangen werden kann. Die Empfehlungen, die wir daraus für unser lebensstilbasiertes Präventionsprogramm abgeleitet haben, sind ähnlich denen, die relativ generisch auch für andere chronische Krankheiten gelten, mit einigen demenzspezifischen Besonderheiten. Wichtig ist dabei neben der Vermeidung und allenfalls sachgerechten Ausleitung von Schwermetallen in der Ernährung eine gute Balance von Omega-3- und Omega-6-Fettsäuren, Vorsicht mit Zucker und mit rasch in Zucker metabolisierbaren Kohlehydraten und daher eher eine ketogene bzw. dieser ähnliche Ernährungsform mit viel Antioxidantien, ein normaler Body-Mass-Index sowie ausreichende Bewegung, gute Sozialkontakte und am besten eine regelmäßige Form der Bewusstseinskultur, etwa Meditation oder Achtsamkeit. Wir haben eine Lebensstildiagnostik zusammengestellt, die allgemein verfügbar ist.

Keywords

Demenz - Lebensstil - Lebensstiländerung - Prävention
 

  • Literatur

  • 1 Fleck L.. Entstehung und Entwicklung einer wissenschaftlichen Tatsache. Einführung in die Lehre vom Denkstil und Denkkollektiv. Mit einer Einleitung hrsg. v. Schäfer L, Schnelle T. Frankfurt: Suhrkamp; (Original erschienen 1935) 1980
    Google Scholar
  • 2 El Dib RP, Atallah AN, Andriolo RB.. Mapping the Cochrane evidence for decision making in health care. J Eval Clin Pract 2007; 13: 689-692
    CrossrefPubMedGoogle Scholar
  • 3 NICE. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (amenden): NICE technology appraisal guidance 111. London, National Institute for Clinical Excellence, 2009
  • 4 Ströhle A, Schmidt DK, Schultz F. et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: A systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriat Psychiatry 2015; 23: 1234-1249
    Google Scholar
  • 5 Schneider LS, Dagerman KS, Higgins JPT. et al. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol 2011; 68 (08) 991-998
    CrossrefPubMedGoogle Scholar
  • 6 Walach H, Loef M.. Using a matrix-analytical approach to synthesizing evidence solved incompatibility problem in the hierarchy of evidence. J Clin Epidemiol 2015; 68: 1251-1260
    CrossrefPubMedGoogle Scholar
  • 7 Loef M.. Moderner Lebensstil und Demenzrisiko – Empirische Untersuchungen. Essen: KVC; 2013
    Google Scholar
  • 8 Walach H, Loef M.. Alzheimer's dementia and lifestyle: Towards a primary prevention. in Hall PA (ed) Social Neuroscience and Public Health: Foundations for the Science of Chronic Disease Prevention Heidelberg New York: Springer; 2013: 193-213
    Google Scholar
  • 9 Walach H, Loef M.. Towards primary prevention of Alzheimer’s disease. Am J Alzheimer's Dis 2012; 01
    Google Scholar
  • 10 Mutter J, Curth A, Naumann J. et al. Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. J Alzheimers Dis 2010; 22: 357-374
    CrossrefPubMedGoogle Scholar
  • 11 Loef M, Walach H.. Iron and copper in Alzheimer's disease: A review. in Martin CR, Preedy VR (eds): Diet and Nutrition in Dementia and Cognitive Decline London: Academic Press; 2015: 563-571
    Google Scholar
  • 12 Loef M, Walach H.. Copper and iron in Alzheimer’s disease: a systematic review and its dietary implications. Br J Nutr 2012; 107: 7-19
    CrossrefPubMedGoogle Scholar
  • 13 Loef M, Mendoza LF, Walach H. Lead (Pb) and the risk of Alzheimer’s disease or cognitive decline: A systematic review. Toxin Reviews 2011; 30: 103-114
    CrossrefGoogle Scholar
  • 14 Song M, Fung TT, Hu FB. et al. Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med 2016; 176: 1453-1463
    CrossrefPubMedGoogle Scholar
  • 15 Orlich MJ, Singh PN, Sabaté J. et al. Vegetarian dietary patterns and the risk of colorectal cancers. JAMA Intern Med 2015; 175: 767-776
    CrossrefPubMedGoogle Scholar
  • 16 Orlich MJ, Fraser GE.. Vegetarian diets in the Adventist Health Study 2: a review of initial published findings. Am J Clin Nutr 2014; 100 (01) 353S-358S
    CrossrefPubMedGoogle Scholar
  • 17 Rondeau V, Jacqmin-Gadda H, Commengas D. et al. Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 2008; 169: 489-496
    CrossrefPubMedGoogle Scholar
  • 18 Guimarães LE, Baker B, Perricone C. et al. Vaccines, adjuvants and autoimmunity. Pharmacol Res 2015; 100: 190-209
    CrossrefPubMedGoogle Scholar
  • 19 Simopoulos AP.. Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain. Mol Neurobiol 2011; 44: 203-215
    CrossrefPubMedGoogle Scholar
  • 20 Eaton SB, Eaton SBI, Sinclair AJ. et al. Dietary intake of long-chain polyunsaturated fatty acids during the Paleolithic. In: Simopoulos AP, ed. The Return of ω3 Fatty Acids into the Food Supply I Land-Based Animal Food Products and Their Health Effects. Basel: Karger; 1998. 83 12-23
    Google Scholar
  • 21 Loef M, Walach H.. The omega-6/omega-3 ratio and dementia or cognitive decline: A systematic review on human studies and biological evidence. J Nutr Gerontol Geriatr 2013; 32: 1-23
    CrossrefPubMedGoogle Scholar
  • 22 Clarke R.. Vitamin B12, folic acid, and the prevention of dementia (editorial). N Engl J Med 2006; 354: 2817-2819
    CrossrefPubMedGoogle Scholar
  • 23 Clarke R, Smith AD, Jobst KA. et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449-1455
    CrossrefPubMedGoogle Scholar
  • 24 McMahon JA, Green TJ, Skeaff CM. et al. A controlled trial of homocysteine lowering and cognitive performance. New Engl J Med 2006; 354: 2764-2772
    CrossrefPubMedGoogle Scholar
  • 25 Liu H, Yang M, Li GM. et al. The MTHFR C677 T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis. J Neurol Sci 2010; 294: 74-80
    CrossrefPubMedGoogle Scholar
  • 26 Annweiler C, Montero-Odasso M, Llewellyn DJ. et al. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013; 37: 147-171
    CrossrefPubMedGoogle Scholar
  • 27 Holick MF.. Vitamin D deficiency. New Engl J Med 2007; 357: 266-281
    CrossrefPubMedGoogle Scholar
  • 28 Littlejohns TJ, Henley WE, Lang IA. et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology 2014; 83: 920-928
    CrossrefPubMedGoogle Scholar
  • 29 de la Monte S, Wands JR.. Alzheimer’s disease is type 3 diabetes – evidence reviewed. J Diabetes Sci Technol 2008; 2: 1101-1113
    CrossrefPubMedGoogle Scholar
  • 30 de la Monte S, Wands JR.. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervious system: Relevance to Alzheimer’s disease. J Alzheimer’s Dis 2005; 7: 45-61
    Google Scholar
  • 31 Mutter J.. Grün essen! Die Gesundheitsrevolution auf Ihrem Teller. Kirchzarten: VAK; 2014
    Google Scholar
  • 32 Longo VD, Mattson MP.. Fasting: Molecular mechanisms and clinical applications. Cell Metabolism 2014; 19: 181-192
    CrossrefPubMedGoogle Scholar
  • 33 Clark IA, Vissel B.. TNF and leptin tell essentially the same story in Alzheimer’s disease. J Alzheimers Dis 2011; 26: 201-205
    CrossrefPubMedGoogle Scholar
  • 34 Witte AV, Fokker M, Gellner R. et al. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci 2009; 106: 1255-1260
    CrossrefPubMedGoogle Scholar
  • 35 Fontana L, Klein S.. Aging, adiposity, and calory restriction. JAMA 2007; 297: 986-994
    CrossrefPubMedGoogle Scholar
  • 36 Loef M, Walach H.. Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the US and China. Obesity 2013; 21: E51-E55
    CrossrefPubMedGoogle Scholar
  • 37 Anstey KJ, Cherbuin N, Budge M. et al. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obesity Reviews 2011; 12
    PubMedGoogle Scholar
  • 38 Pall ML, Levine S.. Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanism, is raised by health promoting factors. Acta Physiologica Sinica 2015; 67: 1-18
    PubMedGoogle Scholar
  • 39 Loef M, Walach H.. Fruit, vegetables, and prevention of cognitive decline or dementia: A systematic review of cohort studies. J Nutr Health Aging 2012; 16: 626-630
    CrossrefPubMedGoogle Scholar
  • 40 Roberson ED, Mucke L.. 100 years and counting: Prospects for defeating Alzheimer's disease. Science 2006; 314: 781-784
    CrossrefPubMedGoogle Scholar
  • 41 Wells RE, Yeh GY, Kerr C. et al. Meditation's impact on default mode network and hippocampus in mild cognitive impairment: A pilot study. Neurosci Lett 2013; 556: 15-19
    CrossrefPubMedGoogle Scholar
  • 42 Pagnoni G, Cekic M.. Age effects on gray matter volume and attentional perfomance in Zen meditation. Neurobiol Aging 2007; 28: 1623-1627
    CrossrefPubMedGoogle Scholar
  • 43 Luders E, Clark K, Narr KL. et al. Enhanced brain connectivity in long-term meditation practitioners. NeuroImage 2011; 57: 1308-1316
    CrossrefPubMedGoogle Scholar
  • 44 Gard T, Hölzel BK, Lazar SW.. The potential effects of meditation on age-related cognitive decline: a systematic review. Ann N Y Acad Sci 2014; 1307: 89-103
    CrossrefPubMedGoogle Scholar
  • 45 Loef M, Walach H.. The combined effects of healthy lifestyle behaviors on all cause mortality: A systematic review and meta-analysis. Prevent Med 2012; 55: 163-170
    CrossrefPubMedGoogle Scholar
  • 46 Loef M, Walach H.. The effects of physical activity on the risk of dementia. a meta-analysis 2012; In prep
    Google Scholar
  • 47 O’Donovan G, Lee I, Hamer M. et al. Association of „weekend warrior“ and other leisure time physical activity patterns with risks for all-cause, cardiovascular disease, and cancer mortality. JAMA Intern Med 2017; 177 (03) 335-342
    CrossrefPubMedGoogle Scholar
  • 48 Bauer J, Qualmann J, Stadtmüller G. et al. Lebenslaufuntersuchungen bei Alzheimer-Patienten: Qualitative Inhaltsanalyse pämorbider Entwicklungsprozesse. In: Kruse A, Hrsg. Psychosoziale Gerontologie: Band 2: Intervention. Göttingen: Hogrefe; 1998: 251-274
    Google Scholar
  • 49 Winblad B, Amouyel P, Andrieu S. et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. The Lancet Neurology 2016; 15: 455-532
    CrossrefPubMedGoogle Scholar
  • 50 Tang EYH, Harrison SL, Errington L. et al. Current developments in dementia risk prediction modelling: An updated systematic review. PLOS ONE 2015; 10: e0136181
    CrossrefPubMedGoogle Scholar
  • 51 Anstey KJ, Cherbuin N, Herath PM. et al. A self-report risk index to predict occurrence of dementia in three independent cohorts of older adults: The ANU-ADRI. PLOS ONE 2014; 9: e86141
    CrossrefPubMedGoogle Scholar
  • 52 Vogt H.. Arzneimittel: Demenz als Folge der Therapie. Dtsch Arztebl International 2017; 114: A-577-580
    Google Scholar